The race for a COVID vaccine has four candidates nearing the finish line — with some getting ready to roll out before the end of the year. But what do the reported efficacy results actually mean and how much will doses cost? We break it down.
Developing nations have the capacity to scale up their responses to the COVID-19 pandemic but they're continually hamstrung by barriers set up by Big Pharma.
Trauma care for rape survivors in South Africa has been crucially underfunded — and now there’s evidence of the HIV-related consequences.
A new study shows that female rape survivors are 60% more likely to contract HIV within a year or two after their rape than women who have not been raped.
Four COVID jabs’ efficacy results have been released within less than a year after the trials had started. But this is far from the norm. Researchers have been working on HIV vaccines for over three decades — and we still don’t have one. Here’s why.
Yvette Raphael describes herself as a ‘professional protester, sjambok feminist and hater of trash’. Government officials would likely refer to her as ‘a rebel’. She’s fought for equality her entire life, she says. And she’s scared of no one.
The dark days of the HIV pandemic are over, but patients still face social stigma and emotional distress that can push...
The police recently announced 30 gender-based violence hot spots to which additional resources will be directed to address violence against women. But the methods they used to identify these areas are flawed —and the hot spots might be elsewhere.
Preliminary findings from the SHINE trial for children with non-severe TB have been released. What do the results mean for young...
In this webinar, we bring you the experiences of three people with HIV who have worked their way through stigma, the side-effects of antiretroviral treatment and living with a chronic condition.